These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9689636)

  • 1. Suppressive effect of antiflammin-2 on compound 48/80-induced conjunctivitis. Role of phospholipase A2s and inducible nitric oxide synthase.
    Li Q; Luyo D; Matteson DM; Chan CC
    Ocul Immunol Inflamm; 1998 Jun; 6(2):65-73. PubMed ID: 9689636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporine inhibits mast cell-mediated conjunctivitis.
    Whitcup SM; Chan CC; Luyo DA; Bo P; Li Q
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2686-93. PubMed ID: 8977483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism.
    Li Q; Luyo D; Hikita N; Whitcup SM; Chan CC
    Int Arch Allergy Immunol; 1996 Mar; 109(3):277-85. PubMed ID: 8620098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of antiflammin peptides in experimental ocular inflammation.
    Chan CC; Tuaillon N; Li Q; Shen DF
    Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory phospholipase A2-potentiated inducible nitric oxide synthase expression by macrophages requires NF-kappa B activation.
    Baek SH; Kwon TK; Lim JH; Lee YJ; Chang HW; Lee SJ; Kim JH; Kwun KB
    J Immunol; 2000 Jun; 164(12):6359-65. PubMed ID: 10843690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with galectin-1 eye drops regulates mast cell degranulation and attenuates the severity of conjunctivitis.
    Mello-Bosnic C; Gimenes AD; Oliani SM; Gil CD
    Eur J Pharmacol; 2018 Aug; 833():124-130. PubMed ID: 29859836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt as a mediator of secretory phospholipase A2 receptor-involved inducible nitric oxide synthase expression.
    Park DW; Kim JR; Kim SY; Sonn JK; Bang OS; Kang SS; Kim JH; Baek SH
    J Immunol; 2003 Feb; 170(4):2093-9. PubMed ID: 12574380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells.
    Won JS; Im YB; Khan M; Singh AK; Singh I
    Glia; 2005 Jul; 51(1):13-21. PubMed ID: 15779087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cis-urocanic acid prevents ocular surface irritation in both IgE -independent and -mediated rat model.
    Jauhonen HM; Laihia J; Oksala O; Viiri J; Sironen R; Alajuuma P; Kaarniranta K; Leino L
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2357-2362. PubMed ID: 28840310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of corticosteroids of adenoviral replication.
    Romanowski EG; Roba LA; Wiley L; Araullo-Cruz T; Gordon YJ
    Arch Ophthalmol; 1996 May; 114(5):581-5. PubMed ID: 8619769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
    Märki F; Pfeilschifter J; Rink H; Wiesenberg I
    FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in experimental allergic conjunctivitis.
    Ko SM; Kim MK; Kim JC
    Cornea; 2000 Jan; 19(1):84-91. PubMed ID: 10632015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice.
    Sade K; Schwartz I; Schwartz D; Wolman Y; Chernichovski T; Fireman E; Iaina A; Kivity S
    Clin Exp Allergy; 2003 Dec; 33(12):1741-6. PubMed ID: 14656364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin 1: more than an anti-phospholipase protein.
    Parente L; Solito E
    Inflamm Res; 2004 Apr; 53(4):125-32. PubMed ID: 15060718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase A2 metabolites regulate inducible nitric oxide synthase in myocytes.
    LaPointe MC; Sitkins JR
    Hypertension; 1998 Jan; 31(1 Pt 2):218-24. PubMed ID: 9453306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of substance P in experimental allergic conjunctivitis in guinea pigs.
    Yamaji M; Takada M; Fujiwara R; Ohishi H; Izushi K; Sugimoto Y; Kamei C
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):637-43. PubMed ID: 9500128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Follicular Conjunctivitis in a Middle-aged Woman.
    Hadjokas NP; Reidy JJ; Farooq AV
    JAMA Ophthalmol; 2018 Jul; 136(7):833-834. PubMed ID: 29801089
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of two new antagonists of secretory PLA2 on TNF, iNOS, and COX-2 expression in activated macrophages.
    Baek SH; Yun SS; Kwon TK; Kim JR; Chang HW; Kwak JY; Kim JH; Kwun KB
    Shock; 1999 Dec; 12(6):473-8. PubMed ID: 10588517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxygenase products regulate nitric oxide and inducible nitric oxide synthase production in interleukin-1beta stimulated vascular smooth muscle cells.
    Hashimoto T; Kihara M; Yokoyama K; Fujita T; Kobayashi S; Matsushita K; Tamura K; Hirawa N; Toya Y; Umemura S
    Hypertens Res; 2003 Feb; 26(2):177-84. PubMed ID: 12627879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.